Dermatology News

The FDA approved Pfizer’s supplemental new drug application for Eucrisa ointment, 2%, for children as young as age 3 months with mild-to-moderate atopic dermatitis, or AD.

A healthy 10-year-old male presents with seven discrete, very pruritic sores on his back. They seem to have originated as typical mosquito bites while he vacationed in Costa Rica for 7 days. The family returned home 12 days prior to presenting to their primary care physician, and since then, the lesions have been slowly but pro-gressively getting larger. The patient and his father also had complained of some transient nausea and vomiting symptoms that have since resolved. Otherwise, the patient has had no other complaints and no fever noted. Some lesions were noted to have had some intermittent drainage. The first time the patient was evaluated, he was diagnosed with impetigo and cellulitis and treated with cephalexin. This did not appear to work, as the le-sions continued to get somewhat larger (Figure 1), with more intermittent oozing of material. The patient was then prescribed clindamycin, which he would not take after the first few doses. As expected, this also did not seem to have any benefit. Shortly thereafter, the mother noted the appearance of dark, black material oozing from one of the lesions with some bubbles (Figure 2).

Rituximab may be a promising option for treatment-refractory childhood-onset lupus erythematosus panniculitis, according to a retrospective, observational case series published in JAMA Dermatology.

A 1-year-old boy presents with a diffuse rash on the body for the past 3 days (Figures 1 and 2). The rash started on his hands, then progressed to include his face, trunk, buttocks, groin, legs and feet. He also developed low-grade fevers and increased fussiness. He has a history of atopic dermatitis that has been difficult to control with hydrocortisone 2.5% ointment. He attends a day care center three times a week.

MAUI, HAWAII — Treating severe acne with isotretinoin comes with several important considerations, two experts told Maui Derm attendees.

Household environments play a significant role in the spread of MRSA in the community, according to a study of transmission events involving children with community-associated MRSA skin and soft tissue infections.

MAUI, HAWAII — There are several ways that dermatologists in the United States can help infectious disease specialists keep the number of measles and coronavirus cases to a minimum, according to a speaker here at Maui Derm for Dermatologists 2020.

MAUI, HAWAII — Several different psoriasis treatments, including those that would provide much needed relief for pediatric patients, are currently making their way through the product pipeline, two panelists at Maui Derm for Dermatologists 2020 said.

MAUI, HAWAII — The triggers of pediatric psoriasis, assessments of the condition’s severity and details about treatments, are among some of the most important takeaways from the recently published American Academy of Dermatology/National Psoriasis Foundation pediatric psoriasis guidelines, according to a speaker here at Maui Derm for Dermatologists 2020.

MAUI, HAWAII — Some of the long-standing obstacles that hinder dermatologists’ ability to practice telemedicine are finally breaking down, according to a speaker here at Maui Derm for Dermatologists 2020.